Akèy › Amiloidoz
Etid klinik pou Amiloidoz ap rekrite nan Etazini
29 etid pou Amiloidoz ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Boston, MA11 etid
- Rochester, MN10 etid
- New York City, NY10 etid
- Dallas, TX9 etid
- Philadelphia, PA7 etid
- St. Louis, MO6 etid
- Baltimore, MD6 etid
- Houston, TX6 etid
- Durham, NC6 etid
- Portland, OR6 etid
- Washington, DC5 etid
- San Diego, CA5 etid
- Nashville, TN5 etid
- Chicago, IL5 etid
- Cleveland, OH5 etid
- Detroit, MI4 etid
- Charlotte, NC4 etid
- Los Angeles, CA4 etid
- Jacksonville, FL4 etid
- San Francisco, CA4 etid
- Seattle, WA4 etid
- Richmond, VA4 etid
- Kansas City, KS3 etid
- Edison, NJ3 etid
- Columbus, OH3 etid
- Austin, TX3 etid
- Aurora, CO3 etid
- Kansas City, MO3 etid
- New Haven, CT3 etid
- Indianapolis, IN3 etid
- Salt Lake City, UT3 etid
- Arlington, VA3 etid
- Mountain View, CA3 etid
- Charleston, SC3 etid
- Atlanta, GA3 etid
- Miami, FL3 etid
Pa eta
- Arizona3 etid
- Colorado5 etid
- Connecticut4 etid
- Distrik Columbia4 etid
- Florid8 etid
- Georgia3 etid
- Illinois5 etid
- Indiana3 etid
- Kalifòni8 etid
- Kansas3 etid
- Maryland7 etid
- Massachusetts11 etid
- Michigan5 etid
- Minnesota10 etid
- Missouri7 etid
- New Jersey3 etid
- New York10 etid
- North Carolina10 etid
- Ohio6 etid
- Oregon6 etid
- Pennsylvania7 etid
- South Carolina4 etid
- Tennessee7 etid
- Texas11 etid
- Utah3 etid
- Virginia4 etid
- Washington4 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07285044A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT05652335Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
Ap rekriteEtid obsèvasyon
Laj 18 a 130 · Tout sèks · Mizajou Sep 23, 2026 · NCT06465810TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Ap rekriteFaz 3
Laj 18 a 85 · Tout sèks · Mizajou Sep 16, 2026 · NCT07052903TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
Ap rekriteFaz 3
Laj 18 a 85 · Tout sèks · Mizajou Sep 15, 2026 · NCT07223203DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07358078ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Sep 8, 2026 · NCT04561518Patisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program
Ap rekriteEtid obsèvasyon
Tout laj · Fanm · Mizajou Sep 8, 2026 · NCT05040373Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF
Ap rekrite
Laj 65 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT05577819Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers
Ap rekriteEtid obsèvasyon
Laj 30 a 80 · Tout sèks · Mizajou Aug 31, 2026 · NCT05489549Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT05145816Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Aug 4, 2026 · NCT06563895Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis
Ap rekriteFaz 4
Laj 18 a 80 · Tout sèks · Mizajou Jul 29, 2026 · NCT07695701A Phase 1 Study of 99mTc-p5+14 in Healthy Volunteers and Patients With AL or ATTR Systemic Amyloidosis
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jul 24, 2026 · NCT05951816[64Cu]FBP8 PET for Early Detection of Intracardiac Thrombus in Amyloid Cardiomyopathy
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Jul 21, 2026 · NCT07560306A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 17, 2026 · NCT07224672A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jul 2, 2026 · NCT07081646Dietary Reporting In The Amyloidoses
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 26, 2026 · NCT05738005Repeat PET/CT Imaging in People With CAPS and Anakinra-Induced Amyloidosis Using an Amyloid-Reactive Peptide to Measure Changes in Organ-Specific Amyloid Load
Ap rekriteFaz 1
Laj 18 a 120 · Tout sèks · Mizajou May 19, 2026 · NCT06974877A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou May 13, 2026 · NCT06158854Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis
Ap rekriteFaz 2
Laj 40 a 90 · Tout sèks · Mizajou Apr 13, 2026 · NCT05758493MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
Ap rekriteFaz 3
Laj 18 a 90 · Tout sèks · Mizajou Mar 27, 2026 · NCT06128629Determining the Association of TTR Stabilizing Therapy With Circulating TTR Amyloid Aggregates Over Time in Patients With ATTR-CM: Longitudinal Biomarker Study
Ap rekriteEtid obsèvasyon
Laj 30 a 80 · Tout sèks · Mizajou Jan 7, 2026 · NCT07196839Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE)
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Dec 31, 2025 · NCT04991103A Study Of Myocardial Stiffness In Amyloidosis With Magnetic Resonance Elastography
Ap rekriteEtid obsèvasyon
Laj 20 ak plis · Tout sèks · Mizajou Dec 26, 2025 · NCT07216469Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.